TY - JOUR
T1 - A single ataxia telangiectasia gene with a product similar to PI-3 kinase
AU - Savitsky, Kinneret
AU - Bar-Shira, Anat
AU - Gilad, Shlomit
AU - Rotman, Galit
AU - Ziv, Yael
AU - Vanagaite, Lina
AU - Tagle, Danilo A.
AU - Smith, Sara
AU - Uziel, Tamar
AU - Sfez, Sharon
AU - Ashkenazi, Maya
AU - Pecker, Iris
AU - Frydman, Moshe
AU - Harnik, Reli
AU - Patanjali, Sankhavaram R.
AU - Simmons, Andrew
AU - Clines, Gregory A.
AU - Sartiel, Adam
AU - Gatti, Richard A.
AU - Chessa, Luciana
AU - Sanal, Ozden
AU - Lavin, Martin F.
AU - Jaspers, N. G.J.
AU - Taylor, A. Malcolm R.
AU - Arlett, Colin F.
AU - Miki, Toru
AU - Weissman, Sherman M.
AU - Lovett, Michael
AU - Collins, Francis S.
AU - Shiloh, Yosef
PY - 1995
Y1 - 1995
N2 - A gene, ATM, that is mutated in the autosomal recessive disorder ataxia telangiectasia (AT) was identified by positional cloning on chromosome 11q22-23. AT is characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, cancer predisposition, radiation sensitivity, and cell cycle abnormalities. The disease is genetically heterogeneous, with four complementation groups that have been suspected to represent different genes. ATM, which has a transcript of 12 kilobases, was found to be mutated in AT patients from all complementation groups, indicating that it is probably the sole gene responsible for this disorder. A partial ATM complementary DNA clone of 5.9 kilobases encoded a putative protein that is similar to several yeast and mammalian phosphatidylinositol-3′ kinases that are involved in mitogenic signal transduction, meiotic recombination, and cell cycle control. The discovery of ATM should enhance understanding of AT and related syndromes and may allow the identification of AT heterozygotes, who are at increased risk of cancer.
AB - A gene, ATM, that is mutated in the autosomal recessive disorder ataxia telangiectasia (AT) was identified by positional cloning on chromosome 11q22-23. AT is characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, cancer predisposition, radiation sensitivity, and cell cycle abnormalities. The disease is genetically heterogeneous, with four complementation groups that have been suspected to represent different genes. ATM, which has a transcript of 12 kilobases, was found to be mutated in AT patients from all complementation groups, indicating that it is probably the sole gene responsible for this disorder. A partial ATM complementary DNA clone of 5.9 kilobases encoded a putative protein that is similar to several yeast and mammalian phosphatidylinositol-3′ kinases that are involved in mitogenic signal transduction, meiotic recombination, and cell cycle control. The discovery of ATM should enhance understanding of AT and related syndromes and may allow the identification of AT heterozygotes, who are at increased risk of cancer.
UR - http://www.scopus.com/inward/record.url?scp=0029057336&partnerID=8YFLogxK
U2 - 10.1126/science.7792600
DO - 10.1126/science.7792600
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0029057336
VL - 268
SP - 1749
EP - 1753
JO - Science
JF - Science
SN - 0036-8075
IS - 5218
ER -